---
title: "Baird Medical signs strategic partnership with Alpmed to co-develop IRE ablation devices"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295407673.md"
description: "Baird Medical has entered a strategic partnership with China-based Alpmed to co-develop and commercialize next-generation irreversible electroporation (IRE) ablation devices globally. Baird Medical will lead regulatory filings, targeting US 510(k) submission by end-2026 and potential clearance in 2027. The company holds worldwide commercialization rights for the first co-developed IRE system for soft-tissue solid tumors, expanding its portfolio beyond microwave ablation into the US market."
datetime: "2026-08-10T12:31:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295407673.md)
  - [en](https://longbridge.com/en/news/295407673.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295407673.md)
generator: "portal-rs"
---

# Baird Medical signs strategic partnership with Alpmed to co-develop IRE ablation devices

-   Baird Medical entered a strategic partnership with China-based Alpmed to co-develop and commercialize next-generation irreversible electroporation ablation devices globally. \* Baird Medical will lead global regulatory filings, including the US, with a 510(k) submission targeted by end-2026 and potential clearance in 2027. \* Baird Medical secured worldwide commercialization rights for the first co-developed IRE system aimed at soft-tissue solid tumors. \* Deal broadens Baird Medical’s portfolio beyond its microwave ablation thyroid franchise as it pushes expansion into the US market. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608100830PRIMZONEFULLFEED9806759) on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [BDMD.US](https://longbridge.com/en/quote/BDMD.US.md)
- [06678.HK](https://longbridge.com/en/quote/06678.HK.md)

## Related News & Research

- [Baird Medical’s BD-GT microwave ablation system wins Pakistan DRAP registration](https://longbridge.com/en/news/296491588.md)
- [IRE: €6.4B capex drives sustainable growth, higher profits, and strong dividends through 2030](https://longbridge.com/en/news/297200220.md)
- [America Great Health reports interim data from ion-modified peptide adjunctive therapy observational study in solid tumors](https://longbridge.com/en/news/296824338.md)
- [Radiopharm Theranostics doses first patient in second cohort of RV-01 Phase 1/2a trial in B7-H3 solid tumors](https://longbridge.com/en/news/297032752.md)
- [How Investors Are Reacting To BeOne Medicines (ONC) First-Line HER2-Positive GEA Immunotherapy Approval](https://longbridge.com/en/news/297146976.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**